[1] Danan G, Benichou C.Causality assessment of adverse reactions to drugs-I.A novel method based on the conclusions of International Consensus Meetings:application to drug-induced liver injuries. J Clin Epidemiol, 1993, 46:1323-1330.
[2] 中华医学会肝病学会分会药物性肝病学组.药物性肝损伤诊治指南.肝脏, 2015, 20:750-767.
[3] 马瑞, 丰小敏, 李秋婷.来曲唑新辅助内分泌疗法治疗绝经后乳腺癌临床观察.山东医药, 2018, 58:72-74.
[4] 何剑芬, 陈卓荣, 胡红波, 等.他莫昔芬和来曲唑对乳腺癌患者宫内膜影响的对比研究.国际医药卫生导报, 2012, 18:3544-3546.
[5] 李荣萍, 任佳 , 吕静 , 等.来曲唑在绝经后乳腺癌新辅助内泌治疗中的应用 .山东医药, 2009, 49:67-69.
[6] Stine JG, Lewis JH. Drug-induced liver injury: a summary of recent advances. Expert Opin Drug Metab Oxicol, 2011, 7:875-890.
[7] Hou FQ, Zeng Z, Wang GQ. Hospital admissions for drug-induced liver injury: clinical features, therapy, and outcomes. Cell Biochem Biophys, 2012, 64: 77-83. |
